Leading Taiwan-Based Biotech Company Signs Pristima® Software Subscription Agreement with Xybion Corporation

Xybion Corporation, a US-based global technology solutions provider for companies operating in the highly regulated industries, announced today that Level Biotechnology Inc., a leading Taiwan-based biotechnology company, has signed a software subscription agreement for Pristima, Xybion’s flagship pre-clinical solution, and Savante™, its popular module for production of FDA compliant SEND submissions.

Please to read the entire article.

You must be logged in to post a comment Login